Last reviewed · How we verify
NCT07526766
A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia
NA trial testing Aerobic and resistance exercises in Fibromuscular Dysplasia in 28 participants. Currently enrolling.
30 April 2027
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 28 |
| Start date | 1 April 2026 |
| Primary completion | 30 April 2027 |
| Estimated completion | 1 July 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Aerobic and resistance exercises
Conditions studied
- Fibromuscular Dysplasia — all drugs for Fibromuscular Dysplasia →
- Spontaneous Coronary Artery Dissection — all drugs for Spontaneous Coronary Artery Dissection →
Sponsor
Mayo Clinic
Who can join
Adults 21 to 65, any sex, with Fibromuscular Dysplasia or Spontaneous Coronary Artery Dissection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exercise in people with Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07526766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Aerobic and resistance exercises
Trials testing the same drug.
- NCT06680557 — Exercises on Children and Adolescents With Type 1 Diabetes Mellitus (T1DM) · NA · completed
- NCT05591794 — Effects of Diet Versus Diet Plus Aerobic and Resistant Exercise Program in Overweight Women · NA · terminated
- NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting
Other recruiting trials for Fibromuscular Dysplasia
Currently open trials in the same condition.
- NCT04804683 — European/International FMD Registry and Initiative · NA · recruiting
- NCT05628948 — Vascular Lab Resource (VLR) Biorepository · recruiting
- NCT04906356 — Canadian SCAD Study · recruiting
- NCT06065852 — National Registry of Rare Kidney Diseases · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07526766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07526766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing